1-5 of 5
Shauna Andersson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial

Clinical Trials & Observations
Gili Kenet, Beatrice Nolan, Bulent Zulfikar, Bulent Antmen, Peter Kampmann, Tadashi Matsushita, Chur-Woo You, Kateryna Vilchevska, Catherine N. Bagot, Azizan Sharif, Flora Peyvandi, Guy Young, Claude Negrier, Jiarui Chi, Barbara Kittner, Christian Sussebach, Fadi Shammas, Baisong Mei, Shauna Andersson, Kaan Kavakli
Journal: Blood
Blood (2024) 143 (22): 2256–2269.
https://doi.org/10.1182/blood.2023021864
Published: 2024
Includes: Supplemental data
Journal Articles

Fitusiran Population Pharmacokinetic and Pharmacodynamic Modeling Utilizing Phase 3 Clinical Trial Data to Confirm Doses Tested in Phase 3 Trials to Support an Antithrombin-Based Dose Regimen

Kumpal Madrasi, Pratik Bhagunde, Sajida Iqbal, Marja Puurunen, Marek Demissie, Shauna Andersson, Sreeraj Macha, Malidi Ahamadi
Journal: Blood
Blood (2023) 142 (Supplement 1): 2614.
https://doi.org/10.1182/blood-2023-189409
Published: 2023
Journal Articles

Fitusiran Reaches People's with Hemophilia and Their Caregivers’ Treatment Expectations: Qualitative Semi-Structured Interviews of Participants of ATLAS-OLE Trial (Interim analysis)

Alok Srivastava, Savita Rangarajan, Cecil Ross, Christina Slota, Dana DiBenedetti, Viridiana Cano, Shauna Andersson, Pronabesh Dasmahapatra, José Bartelt-Hofer, Marion Afonso
Journal: Blood
Blood (2022) 140 (Supplement 1): 7989–7990.
https://doi.org/10.1182/blood-2022-166895
Published: 2022
Journal Articles

Fitusiran Prophylaxis Improves Health-Related Quality of Life in People with Hemophilia a or B, with or without Inhibitors: Results of ATLAS-PPX Study

Gili Kenet, Beatrice Nolan, Tadashi Matsushita, Guy Young, Ting Quan, Viridiana Cano, Christian Sussebach, Shauna Andersson, Baisong Mei, Marion Afonso, Kaan Kavakli
Journal: Blood
Blood (2022) 140 (Supplement 1): 7977–7978.
https://doi.org/10.1182/blood-2022-167169
Published: 2022
Journal Articles

Fitusiran, an Investigational siRNA Therapeutic Targeting Antithrombin for the Treatment of Hemophilia: First Results from a Phase 3 Study to Evaluate Efficacy and Safety in People with Hemophilia a or B without Inhibitors (ATLAS-A/B)

Alok Srivastava, Savita Rangarajan, Kaan Kavakli, Robert Klamroth, Gili Kenet, Liane Khoo, Chur-Woo You, Weiqun Xu, Niel Malan, Laurent Frenzel, Catherine N. Bagot, Oleksandra Stasyshyn, Chia-Yau Chang, Stacey Poloskey, Shauna Andersson, Zhiying Qiu, Baisong Mei, Steven W. Pipe
Journal: Blood
Blood (2021) 138 (Supplement 2): LBA-3.
https://doi.org/10.1182/blood-2021-155018
Published: 2021